相关实验视频
Updated: Jan 10, 2026

07:49
Measuring Local Anaphylaxis in Mice
Published on: October 14, 2014
19.9K
在急诊室的儿科过敏症:从机制到个性化护理
Ghaith K Mansour1, Yara AlGoraini2
1Pharmaceutical Sciences, Alfaisal University College of Pharmacy, Riyadh, SAU.
Cureus
|November 21, 2025
概括
儿科过敏反应是儿童的严重紧急情况,需要立即治疗上腺素. 新的策略旨在改善护理并减少儿科患者的严重结果.
科学领域:
- 儿科过敏和免疫学
- 紧急医疗 紧急医疗
- 免疫学 免疫学 免疫学
背景情况:
- 儿科过敏反应是一种危及生命的过敏反应,其发作和进展不可预测.
- 它涉及通过IgE依赖和非IgE通路激活巨细胞,引起全身免疫反应.
- 目前的管理取决于及时注射上腺素,并由儿科特有的剂量和输送挑战而复杂化.
研究的目的:
- 审查当前对儿科过敏反应的理解和管理.
- 突出儿童过敏反应治疗的挑战,包括剂量和输送.
- 讨论改善患者治疗结果的新兴策略.
主要方法:
- 关于儿童过敏反应管理的文献综述.
- 对IgE依赖和非IgE介导通路的分析.
- 评估当前和新型治疗方法.
主要成果:
- 儿童的过敏反应是一种急性紧急情况,需要立即干预.
- 在儿科患者中,上腺素的剂量和管理存在独特的困难.
- 个性化治疗和基于精度的护理显示出更好的结果的希望.
结论:
- 儿童过敏反应的有效管理需要及时使用上腺素.
- 新兴的方法,如替代途径和量身定制的策略,可能会提高治疗效率.
- 多学科协调对于尽量减少儿科过敏反应的发病率和死亡率至关重要.
相关概念视频
Allergic Reactions
31.9K
Overview
31.9K
Adrenergic Agonists: Therapeutic Uses
1.6K
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
1.6K
Asthma-I: Introduction
3.3K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.3K
Pharmacokinetics in Pediatric Patients: Drug Distribution
247
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
247
Pharmacokinetics in Pediatric Patients: Drug Metabolism
179
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
179
Pharmacokinetics in Pediatric Patients: Drug Excretion
196
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
196

